miRNA
The firm said it has long-term plans to launch multiple miRNA screening tests for cancers that would run in labs or at the point of care using one blood sample.
The company is working with three institutions to recruit about 1,200 case-control participants for its validation study, with plans to launch an LDT next year.
The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant.
COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood
The researchers said that more research into these biomarkers could help with patient stratification and therapy selection.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.